W

J

WEBER , Jeffrey S.

Last name: WEBER

First name: Jeffrey S.

March 4, 2024 (v1)

Publication

Metadata-only

Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)

Weber, Jeffrey S. Schadendorf, Dirk Del Vecchio, Michele

PURPOSE Ipilimumab and nivolumab have each shown treatment benefit for high-risk resected melanoma. The phase III CheckMate 915 trial evaluated adjuvant nivolumab plus ipilimumab versus nivolumab alone in patients with resected stage IIIB-D or IV melanoma. PATIENTS AND METHODS In this randomized, double-blind, phase III trial, 1,833 patients...

Uploaded on: March 6, 2024